Robot model
ROSA
Medtech SA developed ROSA (Robotic Surgical Assistant), a robotic surgery platform with six degrees of freedom and haptic feedback, originally designed for…
- Manufacturer
- Medtech SA
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- superseded
supersededSuperseded by ROSA. The historical entry remains for reference; current coverage tracks the successor.
Overview
Medtech SA developed ROSA (Robotic Surgical Assistant), a robotic surgery platform with six degrees of freedom and haptic feedback, originally designed for neurosurgery and subsequently expanded to orthopedic applications. The ROSA platform is available in specialized configurations for brain, spine, knee, hip, and partial knee procedures, all sharing the same base robot arm with force-torque sensor technology. Medtech SA was founded in 2002 in Montpellier, France and was acquired by Zimmer Biomet in 2016.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
No verified deployments on file. DEPLOY tracks independently-sourced deployment evidence separately from manufacturer capability claims.
Key facts
DOF
Sensor suite
Procedure types
Applications
Specs
Dof
Procedure types
Data & sources
Web sources
2
2 sources backing this record.View all →
Pricing
No verified price is on record for ROSA. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 27, 2026
Added to the verified registry
Regulatory filings (1)
- ce_markce mark · euactive2019-01-01
Applicant: Medtech SA
Safety record
No incidents on record for ROSA.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (2)
- Zimmer Biomet Robotics - Wikipedia · https://en.wikipedia.org/wiki/Zimmer_Biomet_Robotics
- ROSA ONE Brain - Zimmer Biomet · https://www.zimmerbiomet.com/en/products-and-solutions/zb-edge/robotics/rosa-brain.html
Common questions
What is ROSA?
How much does ROSA cost?
Is ROSA actually deployed in the real world?
Who makes ROSA?
Can you buy ROSA?
Is ROSA approved by regulators?
What are alternatives to ROSA?
How does ROSA compare to da Vinci (and Ion)?
Is ROSA a top surgical?
What is ROSA's maturity stage?
Is ROSA still being made?
Where is ROSA deployed?
Is ROSA safe?
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-10-10
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-10-10
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: superseded
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- knowledge-base
- Knowledge base
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for ROSA.Recent coverage
ROSA in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning ROSA from third-party publications. Automatically surfaced; not part of the verified registry record.
Zimmer Biomet: $1 Billion Buyback Target Expands As Next-Generation ROSA Shoulder Begins First Procedures
Zimmer Biomet increased its fiscal 2026 share repurchase expectations to as much as $1 billion as the MedTech company begins the commercial rollout of its next-generation ROSA…
FDA clears Quantum Surgical's liver-cancer-focused ablation robot
Zimmer Biomet Acquires French Robotic Surgery Company
FDA Clearance for Zimmer Biomet’s ROSA Robotic Knee Platform
Zimmer Biomet gets 510(k) for robotic knee surgery system
Zimmer Biomet Buys Medtech for Rosa Surgical Robot
Zimmer Biomet Joins March of Robotics
Zimmer Biomet Acquires Medtech SA, Joins Surgical Robotics Fray
Zimmer pays at least $132m for French robot-assisted surgery firm Medtech SA
Medtech SA: 510(k) From FDA for ROSA Spine Robot
Robot that assists in brain surgery cuts procedure time in half
Machine-readable surfaces
- Markdown mirror: /models/medtech-sa-rosa.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/85d6fdee-8ca7-4297-81e9-1836b6b082e3
- Revision history: /models/medtech-sa-rosa/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
ROSA draws attention at the 49th percentile but verifies reality at the insufficient-data level among surgical robots.
6-month trend
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 20, 2026